exploring the frontiers of bioscience
The Paul G. Allen Frontiers Group takes our Founder’s enduring quest to understand the mysteries of bioscience to a global scale—beyond the science happening within the labs of the Allen Institute—by directing funding to researchers conducting cutting-edge science around the world. Our team is in continuous dialogue with scientists and visionaries in all areas of bioscience, constantly seeking the novel ideas and emerging fields where an early investment could have the power to make a difference for humankind.
The Frontiers Group encourages new ways of doing science, nurtures breakthroughs, and fosters a creative community built on a shared passion for discovery.
We seek the people and approaches at the edges of scientific exploration. We convene scientists and visionaries to identify the fields on the cusp of breakthroughs and generate ideas that will spur new directions in bioscience.
Funding new ideas
To accelerate discoveries, we encourage new approaches to address established scientific questions. We invest in investigators and centers who are gamechangers in their respective fields – innovators who are breaking down walls with the newest technologies and methodologies.
At Frontiers Group events, we bring together our community of creative thinkers and seekers, sparking conversations and collaborations that span disciplines. Our awardees become part of a network of like-minded pioneers who support and challenge each other in their efforts to tackle the biggest questions in bioscience.
News from The Paul G. Allen Frontiers Group
New Allen Distinguished Investigators will tackle unanswered questions about metabolism and the immune system
February 3, 2021
Awards announced today by The Paul G. Allen Frontiers Group will fund research in health, disease, and technology development all centered on the emerging field of immunometabolism
Mouse study uncovers links between unsung brain cells and Huntington’s disease — and possible path for human therapies
October 21, 2020
Astrocytes, once thought of as inert ‘brain glue,’ may turn out to be key players in Huntington’s and other neurodegenerative diseases.
New cell line lets researchers use CRISPR to reversibly switch off genes
October 20, 2020
‘CRISPR interference’ technique enables study of basic cell biology and disease in human stem cells